There is one summary for this bill. Bill summaries are authored by CRS.

Shown Here:
Introduced in House (04/23/2002)

Amends the Internal Revenue Code to provide that the term "taxable vaccine" shall apply to any vaccine against hepatitis A manufactured or produced in the United States or brought into the United States for consumption, use, or warehousing, thus providing that the vaccine excise tax shall apply to such vaccines.